People with type 2 diabetes (T2D) were "LET DOWN" because they were forced to wait for the further treatment. The patients are not getting the extra medication when it was required from the healthcare professionals.
Professor Kamlesh Khunti conducted a study on about 11,000 patients. The study found that only one-third of patients received medication in time. The author used the term "CLINICAL INERTIA" to describe the delay in giving extra medication by the healthcare professionals and putting them at a higher risk. The study was published in the Diabetes, Obesity and Metabolism journal.
A clinical study by Israel-based Oramed shows lower a risk of nocturnal hypoglycemia. The study was conducted on 180 patients with type 2 diabetes (T2D) for 28 days. The study produced a positive result. Oramed is developing ORMD-0181, an oral insulin. The goal of ORMD-0181 is to reduce nocturnal glucose production from the liver of a patient with type 2 diabetes (T2D).
The patient can use oral insulin in addition to injectable insulin, but a minimum number of insulin injections per day. The chief operating officer of the Oramed says oral insulin is not a substitute for insulin injection, but it is an earlier option.
A study conducted on nearly 9,000 patients found that there is a significant association between vitamin D deficiency and diabetic retinopathy. Authors of the study were Dr. Sikarin Upala, Dr. Jason Zhang, and Dr. Anawin Sanguankeo. The authors say people with low vitamin D should undergo a diabetic retinopathy screening.
A study found that an unhappy marriage may slow the progress of diabetes in a man. This is because a nagging wife will be watching and controlling eating behavior of the husband. The control of the wife may improve the health of the husband.
But the control of the wife may annoy the husband. The lead author of the study was Hui Liu, an associate professor of Sociology, Michigan State University. The study was published in the Journals of Gerontology: Social Sciences.
A trial of testosterone therapy was conducted on men with type 2 diabetes (T2D) for a period of six months. The study observed following in patients with type 2 diabetes (T2D).
When the body does not produce enough testosterone, then that condition is known as hypogonadism. The lead author of the study was Dr. Geoffrey Hackett.
The western diet contains junk food and fat. A study found a link between excess consumption of junk food and obesity and the development of type 2 diabetes (T2D).
This type of diet also damage the kidneys. The lead author of the study was Dr. Havovi Chichger, a lecturer in biomedical sciences, Anglia Ruskin University. The study was published in the journal Experimental Physiology.
During the last five years, diabetes in pets (dogs and cats) were up by over 900 percent. As owners are pampering their pets and they are gaining weight. Most of the pets are obese and showing symptoms of hunger and thirst.
Diabetes in pets can be managed with an insulin therapy, diet control and weight loss.
A study found that melatonin (a sleep-inducing hormone) can reduce insulin production in people with a common gene variant (a risk gene). Melatonin is a hormone and the levels of melatonin vary widely throughout the day. The melatonin levels dip during the day and peak at night. Due to the weakening of insulin secretion, the severity of the type 2 diabetes (T2D) was more likely in people working overnight or in people with sleeping disorders.
About one-third of the people have this specific gene variant. The study shows that the effect of melatonin (i.e weakening of insulin secretion) is stronger in people carrying this specific gene variant. The author of the study was Prof Hindrik Mulder. The study was published in the journal Cell Metabolism.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.